| E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer. | E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
Patterson MR, Meijers AS, Ryder EL, Wootton LM, Scarth JA, Evans D, Turner AL, Wasson CW, Darell JE, Theobald DA, Cogan JA, James CD, Wang M, Ladbury JE, Morgan IM, Samson A, Morgan EL, Macdonald A., Free PMC Article | 07/31/2024 |
| Cholesterol uptake in the intestine is regulated by the LASP1-AKT-NPC1L1 signaling pathway. | Cholesterol uptake in the intestine is regulated by the LASP1-AKT-NPC1L1 signaling pathway.
Butt E, Günder T, Stürzebecher P, Kowalski I, Schneider P, Buschmann N, Schäfer S, Bender A, Hermanns HM, Zernecke A. | 06/15/2024 |
| Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1. | Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1.
Zhou L, Zhang L, Guan X, Dong YI, Liu T., Free PMC Article | 06/21/2023 |
| Circular RNA hsa_circ_0003892 promotes the development of papillary thyroid carcinoma by regulating the miR-326/LASP1 axis. | Circular RNA hsa_circ_0003892 promotes the development of papillary thyroid carcinoma by regulating the miR-326/LASP1 axis.
Han P, Liu J, Zhao Q, Li H, Zhang T, Li B, Niu X. | 05/4/2023 |
| TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs. | TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs.
Yang C, Jin X, Liu X, Wu G, Yang W, Pang B, Jiang J, Liao D, Zhang Y., Free PMC Article | 02/11/2023 |
| LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway. | LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway.
Cai Y, Huang Y, Zhang J, Liu X, Zhao F, Zhang K, Xu S, Yang Y, Huang H, Gao Y. | 01/14/2023 |
| Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in Colorectal Cancer | Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in Colorectal Cancer.
Bai L, Gao Z, Jiang A, Ren S, Wang B., Free PMC Article | 11/19/2022 |
| CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis. | CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
Huang T, Guan S, Wang C. | 07/23/2022 |
| Circ_0075804 Regulates the Expression of LASP1 by Targeting miR-1287-5p and Thus Affects the Biological Process of Retinoblastoma. | Circ_0075804 Regulates the Expression of LASP1 by Targeting miR-1287-5p and Thus Affects the Biological Process of Retinoblastoma.
Han Q, Ma L, Shao L, Wang H, Feng M. | 07/16/2022 |
| LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas. | LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.
Vanderheijden C, Vaessen T, Yakkioui Y, Riedl R, Temel Y, Hovinga K, Hoogland G., Free PMC Article | 06/11/2022 |
| Circular RNA circ_0006948 Promotes Esophageal Squamous Cell Carcinoma Progression by Regulating microRNA-3612/LASP1 Axis. | Circular RNA circ_0006948 Promotes Esophageal Squamous Cell Carcinoma Progression by Regulating microRNA-3612/LASP1 Axis.
Tang R, Zhou Q, Xu Q, Lu L, Zhou Y. | 06/11/2022 |
| Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis. | Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N, Ge N, Zhao Y, Yang L, Qin W, Cui Y., Free PMC Article | 05/21/2022 |
| miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1. | miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1.
Zhang Z, Wang Y, Zeng L, Yu K, Wang Y, Luo Y, Liu F, Yang B, Zou Y, Wang L, Huang O., Free PMC Article | 04/23/2022 |
| MicroRNA-326 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through targeting LIM and SH3 protein 1. | MicroRNA-326 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through targeting LIM and SH3 protein 1.
Gao Y, Pan G, Cheng S, Wang Y, Liu F, Shao X. | 03/26/2022 |
| MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1). | MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
Wang Y, Guo D, Li B, Wang Y, Wang B, Wang Z, Wang M, Teng Q. | 03/5/2022 |
| Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis. | Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
Liu Y, Geng X., Free PMC Article | 02/26/2022 |
| LASP-1 interacts with ErbB2 in ovarian cancer cells. | LASP-1 interacts with ErbB2 in ovarian cancer cells.
Sidhanth C, Bindhya S, Shabna A, Krishnapriya S, Manasa P, Nagare RP, Joshua T, Sneha S, Murhekar K, Ganesan TS. | 02/19/2022 |
| ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation. | ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation.
Li R, Hao Y, Wang Q, Meng Y, Wu K, Liu C, Xu L, Liu Z, Zhao L., Free PMC Article | 02/5/2022 |
| LncRNA SNHG16 regulates trophoblast functions by the miR-218-5p/LASP1 axis. | LncRNA SNHG16 regulates trophoblast functions by the miR-218-5p/LASP1 axis.
Yu Z, Zhang Y, Zheng H, Gao Q, Wang H. | 01/29/2022 |
| CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1. | CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1.
Yue L, Wang G, Zhu M. | 01/29/2022 |
| LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-beta1/Smad/Snail Pathway. | LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-β1/Smad/Snail Pathway.
Xue Q, Jiang H, Wang J, Wei D., Free PMC Article | 01/29/2022 |
| Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis. | Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.
You H, Yuan D, Bi Y, Zhang N, Li Q, Tu T, Wei X, Lian Q, Yu T, Kong D, Yang X, Liu X, Liu X, Kong F, Zheng K, Tang R., Free PMC Article | 01/29/2022 |
| HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance. | HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.
Song D, Guo M, Xu S, Song X, Bai B, Li Z, Chen J, An Y, Nie Y, Wu K, Wang S, Zhao Q., Free PMC Article | 12/25/2021 |
| Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1. | Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
Wang S, Qiu J, Wang L, Wu Z, Zhang X, Li Q, Jiang F. | 11/27/2021 |
| Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis. | Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis.
Liu F, Li Z, Guo J, Fang S, Zhou J, Cao B, Liu J, Yi Y, Yuan X, Xu X, Huang O, Wang L, Zou Y. | 11/27/2021 |